Search

The federal government has finalized significant updates to mental health parity requirements for employer health plans and individual private health insurance.

This dashboard monitors progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates. It includes data for 54 countries and tracks progress against 6 different indicators.

The fact that health reform has not been a central issue in this campaign does not mean that the outcome of the election has no consequences for health care.

While former President Trump has stated that overturning Roe v. Wade turned the decision of abortion back to states and “the people are now deciding,” it is a complicated political and legal road…

This report examines the circumstances and health needs of adults who report previous experiences with homelessness. Analysis of KFF’s Racism, Discrimination, and Health survey finds that people who have experienced homelessness have disproportionate health needs and face great socioeconomic challenges than those who have never experienced homelessness.

Under estate recovery, state Medicaid programs are required to recover the costs of long-term care and related hospital and prescription drug services for enrollees ages 55 and older. KFF examines the wide variation in estate recovery practices across states as well as the criticisms of this policy, which have led to federal proposals to modify or reduce it.

More than two years ago President Biden signed into law Medicare drug pricing provisions in the Inflation Reduction Act. KFF’s September Health Tracking Poll examines voter’s views on these provisions and finds that large majorities of voters are unaware of the provisions despite reporting support for them.

Allowing Medicare to negotiate drug prices on behalf of older Americans remains broadly popular across partisans, though many voters are unaware of the new law and the billions of dollars it is expected to save in 2026, a new KFF Health Tracking Poll finds.A large majority (85%) of voters say…

Many physicians fear criminalization if state authorities challenge whether their patients qualify under the narrow and vague exceptions in state bans.

The news today about the efficacy of a new long-acting injectable PrEP, the second such breakthrough announcement in recent months, is nothing short of groundbreaking.